Medite Cancer Diagnostics Inc (MDIT)
Medite Cancer Diagnostics Inc is a common stock listing on OTC Markets for Medite Cancer Diagnostics, Inc., a medical technology company based in Orlando, Florida. The company develops, manufactures, and markets molecular biomarkers, medical devices, and consumables used in the detection, risk assessment, and diagnosis of cancerous and precancerous conditions, as well as related diseases. Its product lineup includes instruments and systems for tissue processing, cooling, sectioning, staining, and robotic coverslipping, along with the SoftKit device for self-collection of samples intended to help assess the health of the female genital tract. Medite Cancer Diagnostics sells through direct channels and distributors in the United States, China, Europe, and North Africa, and serves histology and cytology laboratories in hospitals, research institutions, and independent labs.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-MDIT
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
8.58 K
|
